Amway (Malaysia) Holdings Bhd’s profit after tax (PAT) slipped 7.9% to RM14.4 million for the first half of 2026 (1H26), despite a sharp 257.4% jump in second-quarter earnings, as softer consumer demand and lower sales volumes weighed on the six-month performance.
For 1H26, revenue fell 4.8% to RM533.8 million from RM561 million a year earlier, mainly due to continued weaker demand, partially cushioned by contributions from its cellular health products.
The second quarter painted a stronger picture, with PAT surging 257.4% to RM8.7 million from RM2.4 million previously, mainly following product price adjustments aimed at supporting the group’s target operating margin.
Quarterly revenue also rose 1.9% to RM271.7 million from RM266.7 million, driven by promotional sales of cellular health products, although softer demand persisted across other categories.
Looking ahead, Amway Malaysia expects the consumer environment to remain challenging for the rest of 2026 as households continue to exercise caution in spending.
The group will continue focusing on health and wellbeing products, alongside investments in sales capabilities, product innovation and digital and physical infrastructure.
While cautious consumer spending is expected to continue weighing on sales, Amway Malaysia expects profitability to stabilise on the back of prudent investments and product price adjustments.
